sales 65,030 (international 36,1 / U.S. 28,9 )
Remicade a lucrative rheumatoid arthritis 5,492
(2010)
Conglomerate
Medical devices and diagnostics 25
8,272 (33%)
Pharmaceutical segment 23
7,086 (31%)
Consumer segment 15
2, 342 (16%)
selling, marketing and administrative expenses on sale
19,424 / 61,587 = 32%
Net Income $ 13,334 million
"The source of our enduring strength is a fundamental commitment to
Our Credo
and an operating model that has served us well for decades."
Broadly based in human health
Managed for the long term
Decentralized approach
People and Value
Medical devices and diagnostics 25
8,272 (33%)
Pharmaceutical segment 23
7,086 (31%)
Consumer segment 15
2, 342 (16%)
selling, marketing and administrative expenses on sale
19,424 / 61,587 = 32%
Net Income $ 13,334 million
"The source of our enduring strength is a fundamental commitment to
Our Credo
and an operating model that has served us well for decades."
Broadly based in human health
Managed for the long term
Decentralized approach
People and Value
0 件のコメント:
コメントを投稿